Karyopharm Therapeutics (KPTI) Misses Q1 EPS by 1c

Karyopharm Therapeutics (NASDAQ: KPTI) reported Q1 EPS of ($0.74), $0.01 worse than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Karyopharm Therapeutics (KPTI) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• HP shares slide as tech giant forecasts 2027 PC market slump
• Ledyard Financial Group adds two directors, three retire